Stim Nation: ADHD Patch Approved Despite Concerns

Daytrana, the first patch (similar to a nicotine patch) for ADHD has been approved by the FDA. The patch caused controversy when a FDA reviewer “advised the Food and Drug Administration (FDA) agency that it has too many side-effects.
Dr Levin is an FDA Clinical Reviewer and he recommended against approval of the patch, citing increased incidence of insomnia, anorexia, decreased appetite and the potential for skin sensitization. Later Dr Levin changed his advice to committee“.
The patch is designed to be worn for 9 hours it contains methylphenidate, the same stimulant that is used in Ritalin. The patch is made by Noven Pharmaceuticals Inc. of Miami.
FDA approves first attention deficit patch
Previously on Myomancy: ADHD Patch Under Development

Find Out More:

Books:

April 8th, 2006
ADD / ADHD Medication, ADD / ADHD

Truncated Domes

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Autism Nutrition and Chelation

Natural ADHD Treatments

Golfshop

Discuss the topics raised by this article on the Myomancy Forum.

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism